How many institutions held SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in Q4 2018?

27 institutional investors reported SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share for Q4 2018. Use the holders table for investor-level position and value details.

SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

Q: What does CUSIP P8696W104 represent in this 13F holders report?

CUSIP P8696W104 is the security identifier for SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share used to aggregate holder disclosures.

CUSIP: P8696W104

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Shares, par value US$0.001 per share
Shares outstanding: 71,872,133
Total 13F shares: 12,055,479
Share change: -207,680
Total reported value: $83,665,328
Put/Call ratio: 35%
Price per share: $6.94
Number of holders: 27
Value change: -$1,526,233
Number of buys: 7
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP P8696W104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Vivo Capital, LLC	13F	Company	8.2%	5,900,000	$44,958,000	—	30 Sep 2018	13F
ORBIMED ADVISORS LLC	13F	Company	4%	2,839,500	$21,637,000	—	30 Sep 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	3.4%	2,448,276	$18,656,000	—	30 Sep 2018	13F
Neumann Advisory Hong Kong Ltd	13F	Company	0.52%	374,508	$2,854,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	0.17%	122,721	$943,000	—	30 Sep 2018	13F
Sapphire Star Partners LP	13F	Company	0.14%	100,720	$772,000	—	30 Sep 2018	13F
Invesco Ltd.	13F	Company	0.11%	81,265	$619,000	—	30 Sep 2018	13F
Yorktown Management & Research Co Inc	13F	Company	0.1%	69,792	$537,000	—	30 Sep 2018	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.1%	68,732	$529,000	—	30 Sep 2018	13F
Freedom Investment Management, Inc.	13F	Company	0.06%	43,902	$302,000	—	30 Sep 2018	13F
Spark Investment Management LLC	13F	Company	0.06%	39,600	$301,000	—	30 Sep 2018	13F
SEIZERT CAPITAL PARTNERS, LLC	13F	Company	0.05%	36,062	$275,000	—	30 Sep 2018	13F
NAVELLIER & ASSOCIATES INC	13F	Company	0.04%	30,760	$234,000	—	30 Sep 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	28,497	$219,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	27,717	$213,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.03%	22,374	$170,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	0.01%	8,758	$66,000	—	30 Sep 2018	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0.01%	8,300	$63,000	—	30 Sep 2018	13F
UBS Group AG	13F	Company	0.01%	5,000	$38,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,250	$10,000	—	30 Sep 2018	13F
American Portfolios Advisors	13F	Company	0%	1,200	$9,144	—	30 Sep 2018	13F
IFP Advisors, Inc	13F	Company	0%	1,000	$8,000	—	30 Sep 2018	13F
Financial Gravity Asset Management, Inc.	13F	Company	0%	561	$4,000	—	30 Sep 2018	13F
CWM, LLC	13F	Company	0%	500	$4,000	—	30 Sep 2018	13F
GROUP ONE TRADING LLC	13F	Company	0%	412	$3,000	—	30 Sep 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	260	$2,000	—	30 Sep 2018	13F
Geneos Wealth Management Inc.	13F	Company	0%	150	$1,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	94	$1,000	—	30 Sep 2018	13F

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2018

As of 31 Dec 2018, SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,055,479 shares. The largest 10 holders included Vivo Capital, LLC, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Sapphire Star Partners LP, Yorktown Management & Research Co Inc, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Eqis Capital Management, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 27 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

Q4 2018 holders

Holder diff

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.